CEACAM5 and neoplasm: Our analyses showed that no patient characteristics were associated with neoadjuvant chemotherapy response, including commonly used clinical, serological, and radiographic variables, such as age, carcinoembryonic antigen level, CA199 level, CA724 level, tumor location, clinical tumor stage, clinical node stage, and clinical TNM stage in both the training and validation cohorts.